Effects of strontium ranilate and Hypericum perforatum extract on experimental colitis model in rats
暂无分享,去创建一个
[1] M. Tuzcu,et al. Comparison of the healing effects of silver sulfadiazine cream 1% and the essential oil of Hypericum perforatum on scald burn wound in a rat model , 2014 .
[2] M. Tuzcu,et al. Strontium Chloride: Can It Be a New Treatment Option for Ulcerative Colitis? , 2014, BioMed research international.
[3] J. Nedelec,et al. Effect of strontium-substituted biphasic calcium phosphate on inflammatory mediators production by human monocytes. , 2012, Acta biomaterialia.
[4] M. Morris,et al. Therapeutic Strategies for Bone Metastases and Their Clinical Sequelae in Prostate Cancer , 2012, Current Treatment Options in Oncology.
[5] M. Yamaguchi,et al. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation , 2011, Molecular and Cellular Biochemistry.
[6] M. Zeitz,et al. Innate and adaptive immunity in inflammatory bowel disease. , 2011, World journal of gastroenterology.
[7] K. Mousavizadeh,et al. Anti‐inflammatory effects of 5‐HT3 receptor antagonist, tropisetron on experimental colitis in rats , 2009, European journal of clinical investigation.
[8] M. Medina,et al. Hyperforin: more than an antidepressant bioactive compound? , 2006, Life sciences.
[9] P. Mukherjee,et al. Antibacterial spectrum of Hypericum hookerianum. , 2001, Fitoterapia.
[10] R. Gaynor,et al. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.
[11] E. Vasiliauskas,et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. , 1999, Gastroenterology.
[12] S. Targan,et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. , 1997, The New England journal of medicine.
[13] A. Forbes,et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. , 1997, Lancet.
[14] J. Reimund,et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. , 1996, Gut.
[15] B. Dréno,et al. Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. , 1995, Archives of dermatological research.
[16] T. Macdonald,et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. , 1994, Gastroenterology.
[17] C. Fischer,et al. Dentine hypersensitivity: a review. , 1991, Endodontics & dental traumatology.
[18] H. Scott,et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.